BeiGene (NASDAQ:BGNE) announced Friday that the U.S. Food and Drug Administration (FDA) approved its cancer medicine Tevimbra (tislelizumab-jsgr) in combination with chemotherapy as a first-line ...
Garware Technical Fibres rallied 2.92% to Rs 4,586.65 after the company received an in-principle approval letter from Bombay Stock Exchange (NSE) for bonus issue in the ratio of 4:1.